Complications
Capsular Contracture After Breast Augmentation — Baker Grading, Causes, Treatment
Capsular contracture is the abnormal thickening of the fibrous capsule that the body naturally forms around a breast implant. It is the most common long-term complication after breast augmentation. This article explains the Baker grading system, common mechanisms, prevention strategies, and revision options.
1. The Normal Capsule vs Contracture
Every breast implant becomes surrounded by a thin layer of collagen-based scar tissue — the "capsule." This is a normal foreign-body response and is not in itself a problem. The capsule becomes a clinical issue when it thickens, calcifies, or contracts, distorting the implant and sometimes causing discomfort.
2. Baker Grading System
| Grade | Clinical Findings | Typical Management |
|---|---|---|
| Baker I | Soft, looks and feels natural. | Monitor. |
| Baker II | Slightly firm; appearance still normal. | Monitor; review imaging if indicated. |
| Baker III | Firm; visible distortion of the breast. | Surgical revision typically considered. |
| Baker IV | Firm, distorted, and painful. | Surgical revision usually indicated. |
3. Commonly Cited Mechanisms
Subclinical biofilm
The most widely discussed mechanism is subclinical bacterial biofilm forming on the implant shell. The biofilm can trigger ongoing low-grade inflammation that drives capsule thickening. This concept is the basis for the "14-point plan" used in many evidence-based breast augmentation protocols (e.g., nipple shields, antibiotic irrigation, minimal pocket handling).
Hematoma and seroma
Bleeding or fluid collection around the implant in the early post-op period is associated with higher long-term contracture risk.
Implant rupture
Both intracapsular and extracapsular rupture can drive capsule changes — sometimes through low-grade inflammation, sometimes through direct silicone-tissue contact.
Plane and shell technology
Subglandular (above the muscle) placement historically shows higher contracture rates than dual-plane or subpectoral placement. Macro-textured shells, smooth shells, and nano-textured shells each have different observed contracture patterns in published series.
Other factors
Smoking, radiation therapy, large implants relative to soft-tissue coverage, and personal genetics may also play a role.
4. Prevention Strategies (Evidence-Informed)
- Strict aseptic technique; nipple shielding during incision and dissection.
- Antibiotic-povidone irrigation of the surgical pocket.
- Careful hemostasis; minimize hematoma risk.
- "No-touch" insertion technique (e.g., funnel devices).
- Dual-plane or subpectoral placement when soft-tissue coverage is thin.
- Select shell technology appropriate to anatomy and clinical history.
- Avoid smoking, treat infections promptly, attend follow-up imaging.
5. Diagnosis
Capsular contracture is primarily a clinical diagnosis: firmness on palpation, asymmetry, visible distortion, and pain. Imaging (ultrasound, MRI) helps rule out concurrent implant rupture, seroma, and other capsule-related findings (e.g., late seroma evaluation for BIA-ALCL surveillance in patients with prior textured implants).
6. Surgical Treatment
Capsulotomy
Surgical release of the capsule. Less invasive but with higher recurrence rates compared to capsulectomy in many series. Used selectively.
Capsulectomy
Partial or total removal of the capsule. En-bloc capsulectomy removes the implant and capsule as a single unit and may be appropriate in suspected rupture or BIA-ALCL workup. Total capsulectomy removes the entire capsule but the implant is removed first. Partial capsulectomy removes only diseased portions.
Implant exchange and surface choice
Capsulectomy is typically combined with implant exchange. Surface technology is often changed (e.g., from macro-textured to smooth or nano-textured) based on history and contemporary evidence.
Neo-pocket and plane change
In some cases the implant is moved to a new plane (e.g., from subglandular to dual-plane). Acellular dermal matrix (ADM) may be used to reinforce the new pocket.
7. Recurrence and Outlook
Recurrence after revision varies in published data depending on technique, shell choice, plane, and patient factors. Discussion of personalized recurrence risk is part of pre-revision consultation.
8. When to Seek Evaluation
- New firmness, asymmetry, or visible shape change of the breast.
- Persistent pain or discomfort.
- Suspected implant rupture or late seroma.
- Any rapid change in size or appearance — prompt evaluation is recommended.
Medical disclaimer. Results, recovery time, pain, swelling, and scar appearance vary depending on each patient's anatomy, tissue condition, surgical plan, and healing process. This article is general medical information and does not replace in-person evaluation.
— Dr. Kim Uigeon (Board-certified plastic surgeon, Republic of Korea · UNE Plastic Surgery)